3-Hydroxy-9,10-dimethoxyptercarpan,Methylnissolin
Ukusetyenziswa kweMethylnissolin
I-Methylnisolin (astrapterocarpan) ihlukaniswe kwi-Astragalus membranaceus kwaye inokuthintela ukwanda kweeseli ezibangelwa yi-platelet-derived growth factor (PDGF) - BB, kunye ne-IC50 ye-10 μ M. I-2) iprotheni esebenzayo ye-mitogen (imephu) kinase eyenziwa yi-PDGF-BB.I-Methylnisolin inqanda i-PDGF-BB eyenza ukwanda kweeseli ze-vascular smooth muscle ngokuvimbela i-ERK1 / 2 MAP kinase cascade.
Igama leMethylnissolin
Igama lesiNgesi:
(-)-6aR,11aR-dihydro-3-hydroxy-9,10-dimethoxy-6H-benzofuro[3,2-c][1]-benzopyran
I-Alias yaseTshayina: i-3-hydroxy-9,10-dimethoxy ebomvu ye-sandalwood |I-Astragalus ebomvu
sandalwood |(6aR, 11ar) - 3-hydroxy-9,10-dimethoxy sandalwood ebomvu
Umsebenzi webhayoloji weMethylnissolin
Inkcazo: i-methylnisolin (astrapterocarpan) ihlukaniswe kwi-Astragalus membranaceus
kwaye inokuthintela ukwanda kweeseli ezibangelwa yi-platelet-derived growth factor (PDGF) - BB.
I-IC50 yi-10 μ M. I-Methylnisolin inqanda i-phosphorylation ye-extracellular signal
i-regulated kinase 1/2 (eric1 / 2) mitogen activated protein (map) kinase eyenziwa ngu
PDGF-BB.I-Methylnisolin inqanda i-PDGF-BB eyenza ukwanda kwe-vascular smooth
iiseli zezihlunu ngokuthintela ERK1 / 2 MAP kinase cascade.
Iindidi ezinxulumeneyo: intsimi yophando > > isifo senhliziyo
indlela yomqondiso > > iprotheni tyrosine kinase > > PDGFR
indlela yomqondiso > > MAPK / indlela yesignali ye-ERK > > ERK
indlela yokubonisa > > iiseli zestem kunye ne-Wnt pathway > > ERK
Umbaliso:PDGFR:10 μM (IC50)
ERK1
ERK2
Imbekiselo:[1].Ohkawara S, et al.I-Astrapterocarpan eyedwa kwi-Astragalus membranaceus inqanda ukwanda kweeseli ze-vascular smooth muscle.Eur J Pharmacol.2005 Nov 21;525(1-3):41-7.
Iimpawu zePhysicochemical zeMethylnissolin
Ubuninzi: 1.3 ± 0.1 g / cm3
Indawo yokuBilisa: 428.9 ± 45.0 ° C kwi-760 mmHg
Ifomula yemolekyuli: c17h16o5
Ubunzima beMolekyuli: 300.306
Indawo eDibanisayo: 213.2 ± 28.7 ° C
Ubunzima obuchanekileyo: 300.099762
PSA:57.15000
IlogP:2.45
Uxinzelelo lomphunga: 0.0 ± 1.1 mmHg ku-25 ° C
Refractive Index: 1.612
Jiangsu Yongjian Pharmaceutical Technology Co., Ltd.
I-Jiangsu Yongjian Pharmaceutical Technology Co., Ltd., esekwe ngoMatshi ka-2012, lishishini lobugcisa obuphezulu elidibanisa i-R & D, imveliso kunye neentengiso.Isebenza ikakhulu kwimveliso, uhlengahlengiso kunye nophuhliso lwenkqubo yemveliso yamacandelo asebenzayo emveliso yendalo, izixhobo zesalathiso samayeza esintu kunye nokungcola kweziyobisi.Inkampani ifumaneka kwisiXeko sase-China se-Pharmaceutical City, kwisiXeko saseTaizhou, kwiPhondo laseJiangsu, kubandakanywa nesiseko sokuvelisa i-5000 ye-square meter kunye ne-2000 ye-square meter ye-R & D isiseko.Isebenza ikakhulu kumaziko ophando lwenzululwazi, iiyunivesithi kunye namashishini emveliso ye-decoction kwilizwe lonke.
Ukuza kuthi ga ngoku, siye savelisa ngaphezu kwe-1500 iintlobo ze-reagents zekhompawundi zendalo, kwaye sithelekisa kwaye salinganisa ngaphezu kwe-300 iintlobo zezixhobo zereferensi, ezinokuhlangabezana ngokupheleleyo neemfuno zokuhlolwa kwemihla ngemihla zamaziko ophando lwenzululwazi, iilebhu zeyunivesithi kunye namashishini okuvelisa amaqhekeza e-decoction.
Ngokusekwe kumgaqo wokholo oluhle, inkampani inethemba lokusebenzisana ngokunyanisekileyo nabathengi bethu.Injongo yethu kukusebenzela ukuphuculwa kwamayeza emveli aseTshayina.
I-Advantageous Business Scope yeNkampani
1. R & D, ukuveliswa kunye nokuthengiswa kwezinto ezibhekiselele kwimichiza yamayeza emveli aseTshayina;
2. Iikhompawundi zamayeza emveli aseTshayina ngokweempawu zomthengi
3. Uphando kumgangatho womgangatho kunye nophuhliso lwenkqubo yamayeza emveli aseTshayina (isityalo) isicatshulwa
4. Intsebenziswano yobuchwephesha, ukudluliselwa kunye nophando olutsha lweziyobisi kunye nophuhliso.